Log in to save to my catalogue

The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant

The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b77e6fd6c444788be45374179a2187f

The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant

About this item

Full title

The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Stem cells international, 2018-01, Vol.2018 (2018), p.1-15

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Preponderance of proinflammatory signals is a characteristic feature of all acute and resulting long-term morbidities of the preterm infant. The proinflammatory actions are best characterized for bronchopulmonary dysplasia (BPD) which is the chronic lung disease of the preterm infant with lifelong restrictions of pulmonary function and severe conse...

Alternative Titles

Full title

The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6b77e6fd6c444788be45374179a2187f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b77e6fd6c444788be45374179a2187f

Other Identifiers

ISSN

1687-966X,1687-9678

E-ISSN

1687-9678

DOI

10.1155/2018/9652897

How to access this item